SCHEMBL7349403

SCHEMBL7349403

CCOC(=O)c1nnnn1-c1ccc2ccncc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.42
IDO1 P14902 1/20 0.42
TDO2 P48775 1/20 0.42
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
PPARG P37231 1/20 0.38
NCOA2 Q15596 1/20 0.38
MMP13 P45452 3/20 0.38
MMP2 P08253 2/20 0.38
MMP14 P50281 2/20 0.38
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
TSHR P16473 1/20 0.37
TP53 P04637 1/20 0.37
ALOX12 P18054 1/20 0.37
KMT2A Q03164 2/20 0.36
MAPK1 P28482 1/20 0.36
MEN1 O00255 1/20 0.36
BRAF P15056 1/20 0.36
NOTUM Q6P988 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6765900 0.86 KDM4E (0.53) MAPK10KDM4ENPC1PPARGNCOA2
SCHEMBL14487026 0.80 IDO1 (0.44) MAPK10IDO1TDO2ALDH1A1HPGD
SCHEMBL8163621 0.76 LMNA (0.49) ALDH1A1SMN1; SMN2TSHRTP53ALOX12
SCHEMBL8162436 0.75 TP53 (0.62) KDM4EALDH1A1SMN1; SMN2TSHRTP53
SCHEMBL6172510 0.74 SMN1; SMN2 (0.62) KDM4EALDH1A1SMN1; SMN2TSHRTP53
SCHEMBL5744947 0.73 RAB9A (0.52) KDM4ENPC1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL5376137 0.72 SMN1; SMN2 (0.39) KDM4EALDH1A1SMN1; SMN2TP53MAPK1
SCHEMBL3831656 0.71 ALDH1A1 (0.50) KDM4EALDH1A1SMN1; SMN2TSHRTP53
SCHEMBL3830480 0.71 MAPT (0.46) IDO1TDO2NPC1ALDH1A1SMN1; SMN2
SCHEMBL6041578 0.68 CA12 (0.51) KDM4ENPC1ALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7235575-B2 Guanidine mimics as factor Xa inhibitors BRISTOL MYERS SQUIBB COMPANY (US) 2007-06-26 US disclosed
US-7235575-B2 Guanidine mimics as factor Xa inhibitors BRISTOL MYERS SQUIBB COMPANY (US) 2007-06-26 US disclosed
EP-0991638-A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 2000-04-12 EP disclosed
WO-1998057951-A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-12-23 WO disclosed